Serum levels of gamma interferon in patients with Down's syndrome
Authors:
- 1 January 1995
- journal article
- other
- Published by Springer Nature in Infection
- Vol. 23 (1) , 66-67
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21)The Journal of Immunology, 1992
- Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCRα,β+ cells but abnormal proportions of TCRα,β+, TCRγ,δ+, and CD4+CD45RA+ cells: Evidence for an inefficient release of mature T cells by the DS thymusClinical Immunology and Immunopathology, 1992
- Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial ChallengeAnnals of Internal Medicine, 1988
- Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's SyndromeClinical Immunology and Immunopathology, 1984
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.Journal of Experimental Medicine, 1983
- Altered Cellular Immune Functions in Patients With Down's SyndromeArchives of Pediatrics & Adolescent Medicine, 1981
- Localization of the Gene AVG for the Antiviral Expression of Immune and Classical Interferon to the Distal Portion of the Long Arm of Chromosome 21The Journal of Infectious Diseases, 1976
- Leukocyte function in Down's syndrome quantitative NBT reduction and bactericidal capacityClinical Immunology and Immunopathology, 1974
- SUSCEPTIBILITY OF MONGOLOIDS TO INFECTIONAmerican Journal of Epidemiology, 1948